Obesity in Saudi Arabia

From WikiMD's WELLNESSPEDIA


Saudi Arabia, officially known as the Kingdom of Saudi Arabia, is a country located in the Middle East. As of 2016, it had an adult obesity rate of 35.4%, ranking it 14th globally. This high rate of obesity is a significant public health concern, contributing to a range of chronic diseases including diabetes, heart disease, and cancer.

Obesity in Saudi Arabia[edit]

The high rate of obesity in Saudi Arabia is attributed to a combination of factors including sedentary lifestyles, high consumption of fast food, and cultural norms that discourage physical activity. The government has implemented various initiatives to combat obesity, including public awareness campaigns and regulations on fast food outlets.

Healthcare Facilities[edit]

Several healthcare facilities in Saudi Arabia specialize in weight loss and obesity treatment. These include:

  • Riyadh Military Hospital: This hospital has a specialized Obesity Treatment Center that offers a comprehensive range of services for overweight and obese patients.
  • King Fahd Medical City: This medical city includes a Weight Loss Surgery Center that provides surgical solutions for obesity.
  • King Faisal Specialist Hospital and Research Centre: This hospital offers a multidisciplinary approach to obesity treatment, including dietary counseling, physical therapy, and surgical interventions.

See Also[edit]


the World
Countries
Afghanistan / Albania / Algeria / Andorra / Angola / Antigua and Barbuda / Argentina / Armenia / Australia / Austria / Azerbaijan / Bahamas / Bahrain / Bangladesh / Barbados / Belarus / Belgium / Belize / Benin / Bhutan / Bolivia / Bosnia and Herzegovina / Botswana / Brazil / Brunei / Bulgaria / Burkina Faso / Burundi / Cambodia / Cameroon / Canada / Cape Verde / Central African Republic / Chad / Chile / China / Colombia / Comoros / Costa Rica / Croatia / Cuba / Cyprus / Czech Republic / Democratic Republic of the Congo / Denmark / Djibouti / Dominica / Dominican Republic / Ecuador / Egypt / El Salvador / Equatorial Guinea / Eritrea / Estonia / Eswatini / Ethiopia / Federated States of Micronesia / Fiji / Finland / France / Gabon / Gambia / Georgia / Germany / Ghana / Greece / Grenada / Guatemala / Guinea / Guinea-Bissau / Guyana / Haiti / Honduras / Hungary / Iceland / India / Indonesia / Iran / Iraq / Ireland / Israel / Italy / Ivory Coast / Jamaica / Japan / Jordan / Kazakhstan / Kenya / Kiribati / Kosovo / Kuwait / Kyrgyzstan / Laos / Latvia / Lebanon / Lesotho / Liberia / Libya / Liechtenstein / Lithuania / Luxembourg / Madagascar / Malawi / Malaysia / Maldives / Mali / Malta / Marshall Islands / Mauritania / Mauritius / Mexico / Moldova / Monaco / Mongolia / Montenegro / Morocco / Mozambique / Myanmar / Namibia / Nauru / Nepal / Netherlands / New Zealand / Nicaragua / Niger / Nigeria / North Korea / North Macedonia / Norway / Oman / Pakistan / Palau / Palestine / Panama / Papua New Guinea / Paraguay / Peru / Philippines / Poland / Portugal / Qatar / Republic of the Congo / Romania / Russia / Rwanda / Saint Kitts and Nevis / Saint Lucia / Saint Vincent and the Grenadines / Samoa / San Marino / Saudi Arabia / Senegal / Serbia / Seychelles / Sierra Leone / Singapore / Slovakia / Slovenia / Solomon Islands / Somalia / South Africa / South Korea / South Sudan / Spain / Sri Lanka / Sudan / Suriname / Sweden / Switzerland / Syria / São Tomé and Príncipe / Taiwan / Tajikistan / Tanzania / Thailand / Timor-Leste / Togo / Tonga / Trinidad and Tobago / Tunisia / Turkey / Turkmenistan / Tuvalu / Uganda / Ukraine / United Arab Emirates / United Kingdom / United States / Uruguay / Uzbekistan / Vanuatu / Vatican City / Venezuela / Vietnam / Western Sahara / Yemen / Zambia / Zimbabwe

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Obesity_in_Saudi_Arabia&oldid=5163030"